Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Immatics Biotechnologies GmbH | 678 |
| 2 | Intercontinental Great Brands LLC | 372 |
| 3 | Procter and Gamble Co | 312 |
| 4 | Nestec SA | 301 |
| 5 | Societe des Produits Nestle SA | 262 |
| 6 | Henkel AG and Co KGaA | 242 |
| 7 | Cargill Inc | 208 |
| 8 | Novozymes AS | 208 |
| 9 | Amorepacific Corp | 171 |
| 10 | Alnylam Pharmaceuticals Inc | 146 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 17,144 |
| 2 | A61P | Therapeutic activity (drug indications) | 10,983 |
| 3 | A23L | Foods and beverages (general) | 7,699 |
| 4 | A61Q | Cosmetics, personal care | 7,484 |
| 5 | A23V | Foods, foodstuffs - indexing scheme | 5,842 |
| 6 | C12N | Microorganisms, enzymes | 5,672 |
| 7 | C07K | Peptides | 3,089 |
| 8 | Y02A | Climate change adaptation | 2,208 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 2,058 |
| 10 | A23K | Animal feeds | 1,918 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Glucan compositions and process for preparation thereof | 1989 | Massachusetts Institute of Technology | 279 |
| Glucan composition and process for preparation thereof | 1991 | Massachusetts Institute of Technology | 219 |
| Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4 | 1996 | ALPHA-BETA TECHNOLOGY, INC. | 184 |
| Glucan composition and process for preparation thereof | 1991 | Massachusetts Institute of Technology | 183 |
| Glucan composition and process for preparation thereof | 1992 | Massachusetts Institute of Technology | 167 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Polysaccharides and Plant Cell Walls | 21 |
| 2 | Antifungal resistance and susceptibility | 19 |
| 3 | Food composition and properties | 14 |
| 4 | Fungal Biology and Applications | 11 |
| 5 | Aquaculture disease management and microbiota | 6 |
| 6 | Biofuel production and bioconversion | 6 |
| 7 | Enzyme Production and Characterization | 4 |
| 8 | Immune cells in cancer | 4 |
| 9 | Asthma and respiratory diseases | 3 |
| 10 | Invertebrate Immune Response Mechanisms | 3 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Naohito Ohno | Tokyo University of Pharmacy and Life Sciences | 147 |
| 2 | Yoshiyuki Adachi | Tokyo University of Pharmacy and Life Sciences | 107 |
| 3 | Toshiro Yadomae | Tokyo University of Pharmacy and Life Sciences | 63 |
| 4 | David L. Williams | East Tennessee State University | 34 |
| 5 | Malcolm Finkelman | Cape Cod Hospital | 34 |
| 6 | Kenichi Ishibashi | Tokyo University of Pharmacy and Life Sciences | 33 |
| 7 | Mihai G. Netea | Radboud University Nijmegen | 32 |
| 8 | Noriko N. Miura | Tokyo University of Pharmacy and Life Sciences | 25 |
| 9 | Jianfa Zhang | Nanjing University of Science and Technology | 24 |
| 10 | Václav Větvička | University of Louisville | 20 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity | 2014 | 2177 | Immune cells in cancer |
| Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity | 2014 | 1741 | Epigenetics and DNA Methylation |
| Dectin-1 is required for β-glucan recognition and control of fungal infection | 2006 | 1152 | Antifungal resistance and susceptibility |
| Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity | 2018 | 1080 | Immune Response and Inflammation |
| Syk-Dependent Cytokine Induction by Dectin-1 Reveals a Novel Pattern Recognition Pathway for C Type Lectins | 2005 | 883 | T-cell and B-cell Immunology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Glucan?
What are the major patent assignees working with Glucan?
Who are the most prolific research authors on Glucan?
What are the primary research topics associated with Glucan studies?
What are the dominant patent classification areas for Glucan-related inventions?